Starpharma is a world leader in the development of dendrimer products for pharmaceutical, life science and other applications. Starpharma’s underlying technology is built around dendrimers – a type of synthetic nanoscale polymer that is highly regular in size and structure and well suited to pharmaceutical and medical uses. Starpharma has three core development programs: VivaGel® portfolio, DEP™ drug delivery, and agrochemicals with the company developing a number of products internally and others via commercial partnerships. They are headquartered in Melbourne Australia.
There are currently no products available for this company. Please contact us for more information or browse other companies.